DE60012521D1 - BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD - Google Patents

BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD

Info

Publication number
DE60012521D1
DE60012521D1 DE60012521T DE60012521T DE60012521D1 DE 60012521 D1 DE60012521 D1 DE 60012521D1 DE 60012521 T DE60012521 T DE 60012521T DE 60012521 T DE60012521 T DE 60012521T DE 60012521 D1 DE60012521 D1 DE 60012521D1
Authority
DE
Germany
Prior art keywords
narine
dysbacteriosis
dietetic
consequences
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60012521T
Other languages
English (en)
Other versions
DE60012521T2 (de
Inventor
Taisiya Ivanovna Anisimova
Raisa Aramovna Arakelyan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60012521D1 publication Critical patent/DE60012521D1/de
Publication of DE60012521T2 publication Critical patent/DE60012521T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60012521T 1999-05-18 2000-05-18 BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD Expired - Fee Related DE60012521T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU99109521A RU2146454C1 (ru) 1999-05-18 1999-05-18 Штамм бактерий lactobacillus acidophilus n.v.ep 317/402 "наринэ" ааа, используемый при приготовлении препаратов, диетических и лечебно-профилактических продуктов для лечения дисбактериоза и его последствий
RU99109521 1999-05-18
PCT/RU2000/000183 WO2000070020A1 (en) 1999-05-18 2000-05-18 Bacteria strain lactobacillus acidophilus n.v. ep 317/402 «narine» aaa used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof

Publications (2)

Publication Number Publication Date
DE60012521D1 true DE60012521D1 (de) 2004-09-02
DE60012521T2 DE60012521T2 (de) 2005-09-29

Family

ID=20219495

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60012521T Expired - Fee Related DE60012521T2 (de) 1999-05-18 2000-05-18 BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD

Country Status (5)

Country Link
EP (1) EP1186654B1 (de)
AU (1) AU4630700A (de)
DE (1) DE60012521T2 (de)
RU (1) RU2146454C1 (de)
WO (1) WO2000070020A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2609653C2 (ru) * 2015-03-03 2017-02-02 Общество с ограниченной ответственностью "НПФ "ЭЛЕСТ" Штамм бактерий Lactobacillus acidophilus, используемый для получения кисломолочных продуктов.
WO2020142698A1 (en) 2019-01-05 2020-07-09 Foremost Technologies and Products, Inc. High pressure processing of foods and supplements

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
WO1991011510A1 (fr) * 1990-01-31 1991-08-08 San-Ei Sucrochemical Co., Ltd. $i(LACTOBACTILLUS ACIDOPHILUS F-133, PREPARATION DE BACTERIES D'ACIDE LACTIQUE PREPAREE A PARTIR DE CELUI-CI, ET SON PROCEDE DE PREPARATION)
RU2001578C1 (ru) * 1991-09-27 1993-10-30 Izvekova Tamara G "Способ производства закваски "Наринэ" дл получени кисломолочного концентрата"
RU2035871C1 (ru) * 1992-07-28 1995-05-27 Ерзинкян Арсен Левонович Способ производства кисломолочного продукта
RU2103353C1 (ru) * 1994-05-16 1998-01-27 Институт микробиологии НАН Армении Штамм бактерий lactobacillus acidophilus, используемый для коррекции дисбактериоза при желудочно-кишечных заболеваниях и у больных раком толстой кишки

Also Published As

Publication number Publication date
EP1186654A1 (de) 2002-03-13
EP1186654A4 (de) 2003-02-26
AU4630700A (en) 2000-12-05
DE60012521T2 (de) 2005-09-29
WO2000070020A1 (en) 2000-11-23
EP1186654B1 (de) 2004-07-28
RU2146454C1 (ru) 2000-03-20

Similar Documents

Publication Publication Date Title
ATE290391T1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
ATE407687T1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
DE69802260D1 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
BR0311281A (pt) Probióticos e tolerância oral
NO20030316D0 (no) Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker
EP1095959A3 (de) Kosmetische Zusammensetzung
ATE419331T1 (de) L. salivarius-stamm enthaltende probiotische produkte
HUP0203185A2 (hu) Vérnyomáscsökkentő di- és tripeptideket termelő Lactobacillus helveticus
EA200300862A1 (ru) Связывание эндотоксина под действием лактобактерий и бифидобактерий
NO993221D0 (no) FremgangsmÕte for fremstilling av matkrydder, matingrediens og matvaresammensetningskrydder og anvendelse herav
CA2191213A1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
ATE325614T1 (de) Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
DE69517721T2 (de) Milchsäurebakterien der Gattung Lactobacillus
ATE425248T1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
IL161995A (en) Purified strain of lactic acid bacterium and uses thereof in the preparation of edible compositions, drugs and veterinary products
DE69622855T2 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
ATE274916T1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
EP1985625A3 (de) Synthetische Peptidkonstrukte zur Diagnose und Behandlung von mit Porphyromonas gingivalis assoziierter Periodontitis
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
IL141325A0 (en) Tan-1057 derivatives
HUP0103832A3 (en) Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof
DE60012521D1 (de) BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD
ATE218856T1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee